Literature DB >> 23121522

Geography, ethnicity and "roots" in chronic lymphocytic leukemia.

Rosa Ruchlemer1, Aaron Polliack.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries including Israel, and is less frequent in the Orient, Asia and Middle Eastern Arabic speaking countries. These trends persist in migrants to other countries, continuing into subsequent generations. Biological and genetic disparities have been reported for different ethnic groups. The absence of an association between place of birth and the occurrence of CLL is more in line with a genetic basis for the geographic variations in incidence. Genetic predisposition to CLL is supported by the documented familial aggregation of CLL, with an increased frequency of 8.5-fold among first-degree relatives of patients with CLL and the detection of CLL-like clones in 13.5% of first-degree relatives. It is likely that the development of CLL depends on the interplay of a genetic predisposition with exposure to environmental factors. To better understand the interplay of ethnicity and CLL we reviewed all the available literature on ethnic specific differences for this common form of leukemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23121522     DOI: 10.3109/10428194.2012.740670

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  12 in total

1.  Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations.

Authors:  Loren Gragert; Stephanie Fingerson; Mark Albrecht; Martin Maiers; Matt Kalaycio; Brian T Hill
Journal:  Blood       Date:  2014-09-17       Impact factor: 22.113

2.  Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial.

Authors:  Daobin Zhou; Wei Xu; Hongbing Ma; Chunting Zhao; Yu Hu; Yaozhong Zhao; Depei Wu; Xielan Zhao; Yanjuan He; Jinsong Yan; Chunsen Wang; Fanyi Meng; Jie Jin; Xiaohong Zhang; Kang Yu; Jianda Hu; Yue Lv
Journal:  Invest New Drugs       Date:  2022-01-15       Impact factor: 3.651

3.  A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia.

Authors:  Xu Chen; Stefan Gustafsson; Thomas Whitington; Yan Borné; Erik Lorentzen; Jitong Sun; Peter Almgren; Jun Su; Robert Karlsson; Jie Song; Yi Lu; Yiqiang Zhan; Sara Hägg; Per Svensson; Karin E Smedby; Susan L Slager; Erik Ingelsson; Cecilia M Lindgren; Andrew P Morris; Olle Melander; Thomas Karlsson; Ulf de Faire; Kenneth Caidahl; Gunnar Engström; Lars Lind; Mikael C I Karlsson; Nancy L Pedersen; Johan Frostegård; Patrik K E Magnusson
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

Review 4.  Personalized medicine in CLL: current status and future perspectives.

Authors:  Uri Rozovski; Inbal Hazan-Halevy; Michael J Keating; Zeev Estrov
Journal:  Cancer Lett       Date:  2013-07-20       Impact factor: 8.679

5.  11q23 abnormalities in adult Chinese patients with hematological malignancies.

Authors:  Xiaoli Zhao; Shuang Li; Nianyi Li; Rong Fan; Guowei Lin; Xiaoqin Wang
Journal:  Med Oncol       Date:  2014-07-10       Impact factor: 3.064

6.  Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future.

Authors:  Jennifer R Brown
Journal:  Ther Adv Hematol       Date:  2013-08

7.  Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib.

Authors:  Jörg Mahlich; Shinichiro Okamoto; Akiko Tsubota
Journal:  Pharmacoecon Open       Date:  2017-09

8.  Chronic Lymphocytic Leukemia: Real-World Data From India.

Authors:  V Tejaswi; Deepesh P Lad; Nishant Jindal; Gaurav Prakash; Pankaj Malhotra; Alka Khadwal; Arihant Jain; Sreejesh Sreedharanunni; Manupdesh Singh Sachdeva; Shano Naseem; Neelam Varma; Subhash Varma
Journal:  JCO Glob Oncol       Date:  2020-06

9.  A case of chronic lymphocytic leukemia complicated by autoimmune hemolytic anemia due to ibrutinib treatment.

Authors:  Takaharu Suzuki; Shukuko Miyakoshi; Ayako Nanba; Takayoshi Uchiyama; Keisuke Kawamoto; Sadao Aoki
Journal:  J Clin Exp Hematop       Date:  2018-07-14

10.  Assessing the Relationship between Chronic Lymphoid Leukemia Mortality Rates and Human Development Index: A 26-Year Trend Analysis Using Location-Scale Mixed Effects Model.

Authors:  Parisa Rezanejad Asl; Farid Zayeri; Alireza Moghisi
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.